Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 6/20 | 0.47 |
| ▸ | CA2 | P00918 | 6/20 | 0.47 |
| ▸ | CA12 | O43570 | 5/20 | 0.47 |
| ▸ | CA9 | Q16790 | 5/20 | 0.47 |
| ▸ | RORC | P51449 | 8/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | CA5A | P35218 | 2/20 | 0.41 |
| ▸ | CA7 | P43166 | 2/20 | 0.41 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2638808 | 0.87 | CA1 (0.54) | CA1CA2CA12CA9RORC | |
| SCHEMBL2638989 | 0.86 | CA1 (0.48) | CA1CA2CA12CA9RORC | |
| SCHEMBL2639418 | 0.85 | CA1 (0.47) | CA1CA2CA12CA9RORC | |
| SCHEMBL3859103 | 0.81 | SMN1; SMN2 (0.48) | CA1CA2CA12CA9RORC | |
| SCHEMBL2638496 | 0.80 | CA1 (0.49) | CA1CA2CA12CA9RORC | |
| SCHEMBL2638397 | 0.80 | CA1 (0.51) | CA1CA2CA12CA9RORC | |
| SCHEMBL2639280 | 0.79 | CA1 (0.54) | CA1CA2CA12CA9RORC | |
| SCHEMBL13492097 | 0.79 | CA1 (0.52) | CA1CA2CA12CA9RORC | |
| SCHEMBL2640024 | 0.79 | CA1 (0.59) | CA1CA2CA12CA9RORC | |
| SCHEMBL3838299 | 0.78 | CA1 (0.51) | CA1CA2CA12CA9RORC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1742908-B1 | NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS | HOFFMANN LA ROCHE (CH) | 2009-11-11 | — | — | EP | disclosed |